FMT
First Mercantile Trust Portfolio holdings
AUM
$755M
1-Year Return
28.16%
This Quarter Return
+4.54%
1 Year Return
+28.16%
3 Year Return
+51.25%
5 Year Return
+128.6%
10 Year Return
–
AUM
$873M
AUM Growth
-$8.82M
(-1%)
Cap. Flow
-$40.9M
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
45.88%
Holding
913
New
65
Increased
172
Reduced
585
Closed
73
Top Buys
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$4.89M |
| 2 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$3.65M |
| 3 |
Snowflake
SNOW
|
+$1.85M |
| 4 |
Align Technology
ALGN
|
+$1.15M |
| 5 |
Zoom
ZM
|
+$939K |
Top Sells
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$4.81M |
| 2 |
Schwab U.S Small- Cap ETF
SCHA
|
+$4.22M |
| 3 |
Schwab US Mid-Cap ETF
SCHM
|
+$4.15M |
| 4 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$2.9M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.97M |
Sector Composition
| 1 | Technology | 9% |
| 2 | Consumer Discretionary | 6.27% |
| 3 | Healthcare | 6.19% |
| 4 | Financials | 5.98% |
| 5 | Industrials | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
651
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $110K | 0.01% |
1,603
-189
| -11% | -$13K |
|
652
Forrester Research
FORR
$190M
| $109K | 0.01% |
2,573
-331
| -11% | -$14K |
|
653
Leidos
LDOS
$22.9B
| $109K | 0.01% |
1,127
-939
| -45% | -$90.8K |
|
654
Northwest Bancshares
NWBI
$1.86B
| $109K | 0.01% |
7,539
-1,392
| -16% | -$20.1K |
|
655
Pinnacle West Capital
PNW
$10.5B
| $109K | 0.01% |
1,340
-140
| -9% | -$11.4K |
|
656
Synchrony
SYF
$28B
| $109K | 0.01% |
2,681
-251
| -9% | -$10.2K |
|
|
MODN
657
DELISTED
MODEL N, INC.
MODN
| $109K | 0.01% |
3,091
-94
| -3% | -$3.32K |
|
658
Innospec
IOSP
$2.12B
| $108K | 0.01% |
1,050
| – | – |
|
659
Kura Oncology
KURA
$707M
| $107K | 0.01% |
3,800
+330
| +10% | +$9.29K |
|
660
Monro
MNRO
$527M
| $106K | 0.01% |
1,612
-208
| -11% | -$13.7K |
|
|
NTST
661
NETSTREIT Corp
NTST
$1.72B
| $106K | 0.01% |
5,735
+2,050
| +56% | +$37.9K |
|
662
Gentherm
THRM
$1.12B
| $106K | 0.01% |
1,429
-461
| -24% | -$34.2K |
|
663
Trupanion
TRUP
$1.87B
| $106K | 0.01% |
1,389
-58
| -4% | -$4.43K |
|
|
CCXI
664
DELISTED
ChemoCentryx, Inc.
CCXI
| $106K | 0.01% |
2,072
-243
| -10% | -$12.4K |
|
|
DRNA
665
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $106K | 0.01% |
4,148
-575
| -12% | -$14.7K |
|
666
Assured Guaranty
AGO
$3.9B
| $105K | 0.01% |
2,482
-419
| -14% | -$17.7K |
|
667
Madrigal Pharmaceuticals
MDGL
$10.1B
| $105K | 0.01% |
897
-79
| -8% | -$9.25K |
|
668
PTC Therapeutics
PTCT
$4.52B
| $105K | 0.01% |
2,220
-260
| -10% | -$12.3K |
|
669
ALX Oncology
ALXO
$59.4M
| $104K | 0.01% |
1,404
+195
| +16% | +$14.4K |
|
|
JBGS
670
JBG SMITH
JBGS
$1.42B
| $104K | 0.01% |
3,272
-476
| -13% | -$15.1K |
|
671
TEGNA Inc
TGNA
$3.38B
| $104K | 0.01% |
5,545
| – | – |
|
|
RVNC
672
DELISTED
Revance Therapeutics, Inc.
RVNC
| $104K | 0.01% |
3,707
-497
| -12% | -$13.9K |
|
673
New Jersey Resources
NJR
$4.64B
| $103K | 0.01% |
2,593
-331
| -11% | -$13.1K |
|
674
LiveRamp
RAMP
$1.81B
| $103K | 0.01% |
1,984
-358
| -15% | -$18.6K |
|
675
Spire
SR
$4.43B
| $103K | 0.01% |
1,399
-6
| -0.4% | -$442 |
|